Publication | Closed Access

Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug

ThrombopoiesisThrombosisHematological MalignancyAutoimmune DiseaseBlood PlateletDelayed ThrombocytopeniaMalignant Blood DisorderHematologyImmunologyAutoimmunityDistinct Clinical EntityImmunosuppressionImmunotherapyMedicine